These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 8245178)
1. Evaluation of soluble tumor necrosis factor (TNF) receptors and TNF receptor antibodies in patients with systemic lupus erythematodes, progressive systemic sclerosis, and mixed connective tissue disease. Heilig B; Fiehn C; Brockhaus M; Gallati H; Pezzutto A; Hunstein W J Clin Immunol; 1993 Sep; 13(5):321-8. PubMed ID: 8245178 [TBL] [Abstract][Full Text] [Related]
2. Expression of anti-double stranded DNA idiotype in mixed connective tissue disease and progressive systemic sclerosis. Kubota T; Kanai Y Bull Tokyo Med Dent Univ; 1989 Jun; 36(2):13-8. PubMed ID: 2789110 [TBL] [Abstract][Full Text] [Related]
3. Increased serum levels of immunoglobulins, C-reactive protein, type 1 and type 2 cytokines in patients with mixed connective tissue disease. Bakri Hassan A; Rönnelid J; Gunnarsson I; Karlsson G; Berg L; Lundberg I J Autoimmun; 1998 Oct; 11(5):503-8. PubMed ID: 9802936 [TBL] [Abstract][Full Text] [Related]
4. Fluctuation of anti-endothelial cell antibody titers in " mixed connective tissue disease. Lage LV; de Carvalho JF; Caleiro MT; Yoshinari NH; da Mota LM; Khamashta MA; Cossermelli W Isr Med Assoc J; 2012 Feb; 14(2):84-7. PubMed ID: 22693786 [TBL] [Abstract][Full Text] [Related]
5. Differences in tumor necrosis factor-alpha soluble receptor serum concentrations between patients with Henoch-Schönlein purpura and pediatric systemic lupus erythematosus: pathogenetic implications. Gattorno M; Picco P; Barbano G; Stalla F; Sormani MP; Buoncompagni A; Gusmano R; Borrone C; Pistoia V J Rheumatol; 1998 Feb; 25(2):361-5. PubMed ID: 9489835 [TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features. Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838 [TBL] [Abstract][Full Text] [Related]
7. Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Studnicka-Benke A; Steiner G; Petera P; Smolen JS Br J Rheumatol; 1996 Nov; 35(11):1067-74. PubMed ID: 8948291 [TBL] [Abstract][Full Text] [Related]
8. Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus. Aderka D; Wysenbeek A; Engelmann H; Cope AP; Brennan F; Molad Y; Hornik V; Levo Y; Maini RN; Feldmann M Arthritis Rheum; 1993 Aug; 36(8):1111-20. PubMed ID: 8393677 [TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to angiotensin-converting enzyme 2 in patients with connective tissue diseases. Takahashi Y; Haga S; Ishizaka Y; Mimori A Arthritis Res Ther; 2010; 12(3):R85. PubMed ID: 20470389 [TBL] [Abstract][Full Text] [Related]
10. Diagnosis and risk stratification in patients with anti-RNP autoimmunity. Carpintero MF; Martinez L; Fernandez I; Romero AC; Mejia C; Zang YJ; Hoffman RW; Greidinger EL Lupus; 2015 Sep; 24(10):1057-66. PubMed ID: 25736140 [TBL] [Abstract][Full Text] [Related]
11. Clinical and serological associations of autoantibodies to the Ku70/Ku80 heterodimer determined by a novel chemiluminescent immunoassay. Mahler M; Swart A; Wu J; Szmyrka-Kaczmarek M; Senécal JL; Troyanov Y; Hanly JG; Fritzler MJ Lupus; 2016 Jul; 25(8):889-96. PubMed ID: 27252266 [TBL] [Abstract][Full Text] [Related]